These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 7998955)
21. p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells. Ngiwsara L; Ketudat-Cairns JR; Sawangareetrakul P; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Tim-Aroon T; Wattanasirichaigoon D; Svasti J Ann Hum Genet; 2018 May; 82(3):150-157. PubMed ID: 29282708 [TBL] [Abstract][Full Text] [Related]
22. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients. Ashton LJ; Brooks DA; McCourt PA; Muller VJ; Clements PR; Hopwood JJ Am J Hum Genet; 1992 Apr; 50(4):787-94. PubMed ID: 1550122 [TBL] [Abstract][Full Text] [Related]
23. Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series. Tebani A; Zanoutene-Cheriet L; Adjtoutah Z; Abily-Donval L; Brasse-Lagnel C; Laquerrière A; Marret S; Chalabi Benabdellah A; Bekri S Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196898 [TBL] [Abstract][Full Text] [Related]
24. Mucopolysaccharidosis type I: characterization of novel mutations affecting alpha-L-iduronidase activity. Lee-Chen GJ; Lin SP; Tang YF; Chin YW Clin Genet; 1999 Jul; 56(1):66-70. PubMed ID: 10466419 [TBL] [Abstract][Full Text] [Related]
25. Toward Engineering the Mannose 6-Phosphate Elaboration Pathway in Plants for Enzyme Replacement Therapy of Lysosomal Storage Disorders. Zeng Y; He X; Danyukova T; Pohl S; Kermode AR J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31842258 [TBL] [Abstract][Full Text] [Related]
26. In vivo delivery of human alpha-L-iduronidase in mice implanted with neo-organs. Salvetti A; Moullier P; Cornet V; Brooks D; Hopwood JJ; Danos O; Heard JM Hum Gene Ther; 1995 Sep; 6(9):1153-9. PubMed ID: 8527473 [TBL] [Abstract][Full Text] [Related]
27. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I. Johnson BA; Dajnoki A; Bodamer OA Curr Protoc Hum Genet; 2015 Jan; 84():17.17.1-17.17.8. PubMed ID: 25599668 [TBL] [Abstract][Full Text] [Related]
28. alpha-L-iduronidase in normal and mucopolysaccharidosis-type-I human skin fibroblasts. Taylor JA; Gibson GJ; Brooks DA; Hopwood JJ Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):263-8. PubMed ID: 1900419 [TBL] [Abstract][Full Text] [Related]
29. Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes. Scott HS; Litjens T; Nelson PV; Thompson PR; Brooks DA; Hopwood JJ; Morris CP Am J Hum Genet; 1993 Nov; 53(5):973-86. PubMed ID: 8213840 [TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats. He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309 [TBL] [Abstract][Full Text] [Related]
31. Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Bunge S; Clements PR; Byers S; Kleijer WJ; Brooks DA; Hopwood JJ Biochim Biophys Acta; 1998 Sep; 1407(3):249-56. PubMed ID: 9748610 [TBL] [Abstract][Full Text] [Related]
32. c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications. Peña-Gomar I; Jiménez-Mariscal JL; Cerón M; Rosas-Trigueros J; Reyes-López CA Protein J; 2021 Feb; 40(1):68-77. PubMed ID: 33389473 [TBL] [Abstract][Full Text] [Related]
33. An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life. Kingma SD; Langereis EJ; de Klerk CM; Zoetekouw L; Wagemans T; IJlst L; Wanders RJ; Wijburg FA; van Vlies N Orphanet J Rare Dis; 2013 Jul; 8():99. PubMed ID: 23837464 [TBL] [Abstract][Full Text] [Related]
34. Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase. Anson DS; Taylor JA; Bielicki J; Harper GS; Peters C; Gibson GJ; Hopwood JJ Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):789-94. PubMed ID: 1320379 [TBL] [Abstract][Full Text] [Related]
35. Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I. Kwak MJ; Huh R; Kim J; Park HD; Cho SY; Jin DK BMC Med Genet; 2016 Aug; 17(1):58. PubMed ID: 27520059 [TBL] [Abstract][Full Text] [Related]
36. Comparison of Endovascular and Intraventricular Gene Therapy With Adeno-Associated Virus-α-L-Iduronidase for Hurler Disease. Janson CG; Romanova LG; Leone P; Nan Z; Belur L; McIvor RS; Low WC Neurosurgery; 2014 Jan; 74(1):99-111. PubMed ID: 24077583 [TBL] [Abstract][Full Text] [Related]
37. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S). Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232 [TBL] [Abstract][Full Text] [Related]
38. Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase. Weber B; Hopwood JJ; Yogalingam G Protein Expr Purif; 2001 Mar; 21(2):251-9. PubMed ID: 11237686 [TBL] [Abstract][Full Text] [Related]
39. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein. Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM Mol Pharm; 2011 Aug; 8(4):1342-50. PubMed ID: 21667973 [TBL] [Abstract][Full Text] [Related]
40. A novel compound mutation in alpha-L-iduronidase gene causes mucopolysaccharidosis type I. Li Y; Tang X; Meng Y; Luo G; Yu X J Genet; 2019 Sep; 98():. PubMed ID: 31544795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]